Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of ErbB Receptors in Cancer Cell Migration and Invasion
Aline Appert-Collin, P. Hubert, Gérard Crémel, et al.
Frontiers in Pharmacology (2015) Vol. 6
Open Access | Times Cited: 285

Showing 1-25 of 285 citing articles:

Risk Factors and Preventions of Breast Cancer
Yi-Sheng Sun, Zhao Zhao, Zhang-Nv Yang, et al.
International Journal of Biological Sciences (2017) Vol. 13, Iss. 11, pp. 1387-1397
Open Access | Times Cited: 1536
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch, et al.
European Journal of Immunology (2019) Vol. 49, Iss. 10, pp. 1457-1973
Open Access | Times Cited: 876
Guidelines for the use of flow cytometry and cell sorting in immunological studies*
Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch, et al.
European Journal of Immunology (2017) Vol. 47, Iss. 10, pp. 1584-1797
Open Access | Times Cited: 507
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 12, pp. 2708-3145
Open Access | Times Cited: 315
Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials
Amaia Eleonora Maennling, Mehmet Kemal Tur, Marcus Niebert, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1826-1826
Open Access | Times Cited: 176
Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma
Chiara Gai, Francesco Camussi, Roberto Broccoletti, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 169
Advances in antibody-based therapy in oncology
Sacha Zinn, Rodrigo Vazquez-Lombardi, Carsten Zimmermann, et al.
Nature Cancer (2023) Vol. 4, Iss. 2, pp. 165-180
Closed Access | Times Cited: 120
Targeted contrast agents and activatable probes for photoacoustic imaging of cancer
Zhenxiang Zhao, Chelsea B. Swartchick, Jefferson Chan
Chemical Society Reviews (2022) Vol. 51, Iss. 3, pp. 829-868
Open Access | Times Cited: 93
Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer
Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea‐Ilies, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1320-1320
Open Access | Times Cited: 77
Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway
Gang Wang, Rui Cao, Yongzhi Wang, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 111
The RTK Interactome: Overview and Perspective on RTK Heterointeractions
Michael Paul, Kalina Hristova
Chemical Reviews (2018) Vol. 119, Iss. 9, pp. 5881-5921
Open Access | Times Cited: 91
Primary Cilia as Signaling Hubs in Health and Disease
Yuhei Nishimura, Kousuke Kasahara, Takashi Shiromizu, et al.
Advanced Science (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 85
Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and HER2-Mutated Breast Cancer
Denis M. Collins, Neil T. Conlon, Srinivasaraghavan Kannan, et al.
Cancers (2019) Vol. 11, Iss. 6, pp. 737-737
Open Access | Times Cited: 85
The existence of a nonclassical TCA cycle in the nucleus that wires the metabolic-epigenetic circuitry
Xujun Liu, Wenzhe Si, Lin He, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 62
HER3 in cancer: from the bench to the bedside
Lucía Gandullo‐Sánchez, Alberto Ocaña, Atanasio Pandiella
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 54
Molecular pathways associated with oxidative stress and their potential applications in radiotherapy (Review)
Rui Liu, Yan Bian, Lin Liu, et al.
International Journal of Molecular Medicine (2022) Vol. 49, Iss. 5
Open Access | Times Cited: 49
The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein
Lauren M. Lucas, Vipasha Dwivedi, Jared I. Senfeld, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 1, pp. 18-47
Open Access | Times Cited: 48
Hirsutine, an Emerging Natural Product with Promising Therapeutic Benefits: A Systematic Review
Md. Shimul Bhuia, Polrat Wilairatana, Jannatul Ferdous, et al.
Molecules (2023) Vol. 28, Iss. 16, pp. 6141-6141
Open Access | Times Cited: 33
Autophagy and Breast Cancer: Connected in Growth, Progression, and Therapy
Qitong Wu, Dipali Sharma
Cells (2023) Vol. 12, Iss. 8, pp. 1156-1156
Open Access | Times Cited: 31
Therapeutic potentials of ononin with mechanistic insights: A comprehensive review
Md. Shimul Bhuia, Asma Aktar, Raihan Chowdhury, et al.
Food Bioscience (2023) Vol. 56, pp. 103302-103302
Closed Access | Times Cited: 23
Molecular docking, QSAR, and simulation analyses of EGFR-targeting phytochemicals in non-small cell lung cancer
Md. Enamul Kabir Talukder, Md. Farhan Atif, Noimul Hasan Siddiquee, et al.
Journal of Molecular Structure (2024) Vol. 1321, pp. 139924-139924
Closed Access | Times Cited: 9
EBP1 nuclear accumulation negatively feeds back on FERONIA-mediated RALF1 signaling
Chiyu Li, Xuanming Liu, Xiaonan Qiang, et al.
PLoS Biology (2018) Vol. 16, Iss. 10, pp. e2006340-e2006340
Open Access | Times Cited: 72
Imbalance of the reciprocally inhibitory loop between the ubiquitin-specific protease USP43 and EGFR/PI3K/AKT drives breast carcinogenesis
Lin He, Xinhua Liu, Jianguo Yang, et al.
Cell Research (2018) Vol. 28, Iss. 9, pp. 934-951
Open Access | Times Cited: 71
Anticancer properties of tocotrienols: A review of cellular mechanisms and molecular targets
Marina Montagnani Marelli, Monica Marzagalli, Fabrizio Fontana, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 2, pp. 1147-1164
Open Access | Times Cited: 60
Using Network Pharmacology and Molecular Docking to Explore the Mechanism of Shan Ci Gu (Cremastra appendiculata) Against Non-Small Cell Lung Cancer
Yan Wang, Yunwu Zhang, Yujia Wang, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top